Anatomical and functional outcomes of subthreshold micropulse laser versus intravitreal ranibizumab injection in treatment of diabetic macular edema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anatomical and functional outcomes of subthreshold micropulse laser versus intravitreal ranibizumab injection in treatment of diabetic macular edema ; volume:6 ; number:1 ; day:3 ; month:12 ; year:2020 ; pages:1-8 ; date:12.2020
International Journal of Retina and Vitreous ; 6, Heft 1 (3.12.2020), 1-8, 12.2020
- Urheber
-
Abdelrahman, Amr
Massoud, Wagiha
Elshafei, Ahmed Mohamed Kamal
Genidy, Mahmoud
Abdallah, Raafat Mohyeldeen Abdelrahman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-020-00265-6
- URN
-
urn:nbn:de:101:1-2021011218550904668346
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abdelrahman, Amr
- Massoud, Wagiha
- Elshafei, Ahmed Mohamed Kamal
- Genidy, Mahmoud
- Abdallah, Raafat Mohyeldeen Abdelrahman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Short pulse grid and subthreshold micropulse laser (the sandwich grid) plus intravitreal ranibizumab for the treatment of diabetic macular edema
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Study of Nonperfusion Area Changes after Ranibizumab Intravitreal Injection for Diabetic Macular Edema by Means of Widefield OCT Angiography
Retinal Blood Flow as a Predictor of Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Central Retinal Vein Occlusion
Intravitreal ranibizumab reduced ocular blood flow and aqueous cytokine levels and improved retinal morphology in patients with diabetic macular edema
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Short pulse grid and subthreshold micropulse laser (the sandwich grid) plus intravitreal ranibizumab for the treatment of diabetic macular edema
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Study of Nonperfusion Area Changes after Ranibizumab Intravitreal Injection for Diabetic Macular Edema by Means of Widefield OCT Angiography
Retinal Blood Flow as a Predictor of Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Central Retinal Vein Occlusion
Intravitreal ranibizumab reduced ocular blood flow and aqueous cytokine levels and improved retinal morphology in patients with diabetic macular edema
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Short pulse grid and subthreshold micropulse laser (the sandwich grid) plus intravitreal ranibizumab for the treatment of diabetic macular edema
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Study of Nonperfusion Area Changes after Ranibizumab Intravitreal Injection for Diabetic Macular Edema by Means of Widefield OCT Angiography
Retinal Blood Flow as a Predictor of Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Central Retinal Vein Occlusion
Intravitreal ranibizumab reduced ocular blood flow and aqueous cytokine levels and improved retinal morphology in patients with diabetic macular edema